Related Experiment Video

Updated: Jul 3, 2026

High-Throughput In Vitro Assay using Patient-Derived Tumor Organoids
06:25

High-Throughput In Vitro Assay using Patient-Derived Tumor Organoids

Published on: June 14, 2021

Anti-tumor activity of phenoxodiol: from bench to clinic

Ayesha B Alvero1, Michael Kelly, Patti Rossi

  • 1Yale University, Department of Obstetrics and Gynecology and Reproductive Sciences, School of Medicine, 333 Cedar Street, New Haven, CT 06520, USA.

Future Oncology (London, England)
|August 8, 2008
PubMed

Insights

Phenoxodiol, an isoflavone derivative, effectively induces apoptosis and overcomes chemoresistance in cancer cells. It also enhances the efficacy of standard chemotherapy agents like carboplatin and paclitaxel.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Chemoresistant tumors present a significant challenge in cancer treatment.
  • Cancer cells often evade chemotherapy-induced apoptosis via antiapoptotic proteins.
  • Novel therapeutic strategies are needed to overcome drug resistance.

Purpose of the Study:

  • To review the molecular mechanisms of phenoxodiol.
  • To discuss phenoxodiol's potential in overcoming cancer chemoresistance.
  • To summarize phenoxodiol's clinical progress.

Main Methods:

  • Literature review of phenoxodiol's in vitro and in vivo studies.
  • Analysis of phenoxodiol's effects on apoptosis.
  • Evaluation of phenoxodiol's chemosensitizing properties.

Main Results:

  • Phenoxodiol induces apoptosis in cancer cells, including chemoresistant types.
  • Phenoxodiol demonstrates chemosensitizing effects when combined with carboplatin and paclitaxel.
  • The molecular mechanisms underlying phenoxodiol's action are being characterized.

Conclusions:

  • Phenoxodiol shows promise as a therapeutic agent against chemoresistant cancers.
  • Phenoxodiol has the potential to improve outcomes when used with conventional chemotherapy.
  • Further clinical evaluation of phenoxodiol is warranted.

More Related Videos

In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis07:25

In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis

Published on: May 4, 2017

Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery13:19

Quantifying Antibody-Dependent Cellular Cytotoxicity in a Tumor Spheroid Model: Application for Drug Discovery

Published on: April 26, 2024

Related Concept Videos

Preclinical Development: Overview01:28

Preclinical Development: Overview

Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...